Gennova's MRNA Covid-19 Vaccine Gets Drug Regulator's Nod For Phase II/III Trial

New Delhi, Aug 24 (UNI) Pune-based biotechnology firm Gennova Biopharmaceuticals Ltd has received approval from the Drug Controller General of India (DCGI) to conduct a phase II/III trial of its Covid-19 vaccine candidate in the country, the Centre informed on Tuesday.

Leave a Reply

Your email address will not be published. Required fields are marked *

New Delhi, Aug 24 (UNI) Pune-based biotechnology firm Gennova Biopharmaceuticals Ltd has received approval from the Drug Controller General of India (DCGI) to conduct a phase II/III trial of its Covid-19 vaccine candidate in the country, the Centre informed on Tuesday.

Leave a Reply

Your email address will not be published. Required fields are marked *